A phase I/II trial of cyclophosphamide, carfilzomib, thalidomide, and dexamethasone (CYCLONE) in patients with newly diagnosed multiple myeloma.
Joseph Mikhael
Research Funding - Onyx
Craig B. Reeder
No relevant relationships to disclose
Edward N. Libby
No relevant relationships to disclose
Luciano Costa
No relevant relationships to disclose
Angela Mayo
No relevant relationships to disclose
P. Leif Bergsagel
No relevant relationships to disclose
Francis Buadi
No relevant relationships to disclose
Nicholas Pirooz
No relevant relationships to disclose
Jade Marie Lubben
No relevant relationships to disclose
Amylou C. Dueck
No relevant relationships to disclose
A. Keith Stewart
Honoraria - Celgene; Onyx
Research Funding - Onyx